Larry Zeitlin
Gründer bei Mapp Biopharmaceutical, Inc.
Profil
Larry Zeitlin is the founder and President of Mapp Biopharmaceutical, Inc. which is founded in 2003.
He is currently a Director at Leaf Biopharmaceutical, Inc. Dr. Zeitlin received his undergraduate and doctorate degrees from The Johns Hopkins University in 1995.
Aktive Positionen von Larry Zeitlin
Unternehmen | Position | Beginn |
---|---|---|
Mapp Biopharmaceutical, Inc.
Mapp Biopharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Mapp Biopharmaceutical, Inc. develops prevention and treatment of infectious diseases. The company was founded by Kevin Whaley and Larry Zeitlin in 2003 and is headquartered in San Diego, CA. | Gründer | 01.01.2003 |
Leaf Biopharmaceutical, Inc.
Leaf Biopharmaceutical, Inc. BiotechnologyHealth Technology Leaf Biopharmaceutical, Inc. focuses on pharmaceutical research and development of monoclonal antibody products for the treatment and prevention of viral and infectious disease. It also offers consulting services in the fields of biotechnology, pharmaceutical research and development, and laboratory testing and specializes in pharmaceutical research and development in relation to biodefense. The company is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Larry Zeitlin
The Johns Hopkins University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Mapp Biopharmaceutical, Inc.
Mapp Biopharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Mapp Biopharmaceutical, Inc. develops prevention and treatment of infectious diseases. The company was founded by Kevin Whaley and Larry Zeitlin in 2003 and is headquartered in San Diego, CA. | Health Technology |
Leaf Biopharmaceutical, Inc.
Leaf Biopharmaceutical, Inc. BiotechnologyHealth Technology Leaf Biopharmaceutical, Inc. focuses on pharmaceutical research and development of monoclonal antibody products for the treatment and prevention of viral and infectious disease. It also offers consulting services in the fields of biotechnology, pharmaceutical research and development, and laboratory testing and specializes in pharmaceutical research and development in relation to biodefense. The company is headquartered in San Diego, CA. | Health Technology |